Description
Anti-Complement C5 Antibody
| Catalog number: | B2011208 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.5 mg |
| Molecular Weight or Concentration: | > 4.5 mg/mL |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 2-8 C |
| Keywords: | anti-Complement C5 Polyclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Palviainen MJ, Junnikkala S, Raekallio M, Meri S, Vainio O. Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep Acta Vet Scand. 2015 Mar 15;57(1):15.
- Song L, Ge T, Li Z, Sun J, Li G, Sun Y, Fang L, Ma YJ, Garred P. Artesunate: A natural product-based immunomodulator involved in human complement Biomed Pharmacother. 2021 Apr;136:111234.
- Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway J Exp Med. 1987 Jun 1;165(6):1494-507.
- Bhakdi S, Ey P, Bhakdi-Lehnen B. Isolation of the terminal complement complex from target sheep erythrocyte membranes Biochim Biophys Acta. 1976 Feb 6;419(3):445-57.
- Kapil A, Sharma S. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway J Pharm Pharmacol. 1994 Nov;46(11):922-3.
- Cairns L, Rosen FS, Borel Y. Mice naturally tolerant to C5 have T cells that suppress the response to this antigen Eur J Immunol. 1986 Oct;16(10):1277-82.
- Dekkers G, Brouwer MC, Jeremiasse J, Kamp A, Biggs RM, van Mierlo G, Lauder S, Katti S, Kuijpers TW, Rispens T, Jongerius I. Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants J Immunol. 2020 Oct 1;205(7):1778-1786.
- Durigutto P, Macor P, Ziller F, De Maso L, Fischetti F, Marzari R, Sblattero D, Tedesco F. Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 PLoS One. 2013;8(3):e58696.
- Tanimoto K, Cooper NR, Johnson JS, Vaughan JH. Complement fixation by rheumatoid factor J Clin Invest. 1975 Mar;55(3):437-45.
